<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="acid (ATA) could easily be polymerized in water by reacting" exact="salicylic acid" post="with formaldehyde, sulphuric acid, and sodium nitrite [49]. Reymen"/>
 <result pre="water by reacting salicylic acid with formaldehyde, sulphuric acid, and" exact="sodium nitrite" post="[49]. Reymen et al. displayed that owing to an"/>
 <result pre="Other neutral antiviral molecules are ascorbic and dehydroascorbic acids [52]," exact="triclosan" post="[53] and the camphor imine derivatives. Various studies conducted"/>
 <result pre="effect increased. Chen et al. studied the use of poly-" exact="l-glutamine" post="(PGN) conjugated with Zanamivir and demonstrated that this system"/>
 <result pre="studied the consequence of adding 3% sodium pentaborate pentahydrate, 0.03%" exact="triclosan" post="and 7% glucapon solution to cotton textile [90]. They"/>
 <result pre="were demonstrated by Orsi et al. [143]. They revealed that" exact="dextran" post="sulphate, scleroglucan, and lambda carrageenan have antiviral effects on"/>
 <result pre="gum. Furthermore, these polymers influence HSV-2, with similar effect like" exact="dextran" post="sulphate, glyloid sulphate 4324 and lambda carrageenan which is"/>
 <result pre="delivery: Development, characterization and optimizationSaudi Pharm. J.201725324310.1016/j.jsps.2015.06.00328223860 58.YueI.C.PoffJ.CortésM.E.SinisterraR.D.FarisC.B.HildgenP.LangerR.ShastriV.P.A novel polymeric" exact="chlorhexidine" post="delivery device for the treatment of periodontal diseaseBiomaterials2004253743375010.1016/j.biomaterials.2003.09.11315020150 59.TalluryP.AirrabeelliR.LiJ.PaquetteD.KalachandraS.Release"/>
 <result pre="of cell-targeting groups for influenza A virus treatmentPolym. Chem.201892116212310.1039/C8PY00116B 62.LeeC.M.WeightA.K.HaldarJ.WangL.KlibanovA.M.ChenJ.Polymer-attached" exact="zanamivir" post="inhibits synergistically both early and late stages of influenza"/>
 <result pre="Sci.2019717818610.1039/C8BM01221K 66.SmithA.A.A.KrygerM.B.L.WohlB.M.Ruiz-SanchisP.ZuwalaK.TolstrupM.ZelikinA.N.Macromolecular (pro)drugs in antiviral researchPolym. Chem.201456407642510.1039/C4PY00624K 67.KrygerM.B.L.WohlB.M.SmithA.A.A.ZelikinA.N.Macromolecular prodrugs of" exact="ribavirin" post="combat side effects and toxicity with no loss of"/>
 <result pre="infected by influenza virusAntiviral Res.20056811612310.1016/j.antiviral.2005.07.00816214231 71.RonerM.R.CarraherC.E.DhanjiS.BarotG.Antiviral and anticancer activity of" exact="cisplatin" post="derivatives of tiloroneJ. Inorg. Organomet. Polym. Mater.20081837438310.1007/s10904-008-9219-732214933 72.RonerM.R.CarraherC.E.Cisplatin derivatives"/>
 <result pre="against infection of tobacco mosaic virusMacromol. Symp.19959923924210.1002/masy.19950990125 137.SanoY.Antiviral activity of" exact="chondroitin sulfate" post="against infection by tobacco mosaic virusCarbohydr. Polym.19973312512910.1016/S0144-8617(97)00029-5 138.WeiyueS.YingL.KanamotoT.AsaiD.TakemuraH.Elucidation of"/>
 <result pre="CE, Dhanji S, Barot G. Antiviral and anticancer activity of" exact="cisplatin" post="derivatives of Tilorone. J Inorg Organomet Polym Mater 2008;18:374–83"/>
</results>
